Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 51,100
-4,900 (-8.75%)
At close: Dec 5, 2025
Hanall Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,594,851 | 1,959,952 | 2,245,705 | 902,290 | 1,077,892 | 1,919,220 | Upgrade
|
| Market Cap Growth | 13.84% | -12.72% | 148.89% | -16.29% | -43.84% | 3.31% | Upgrade
|
| Enterprise Value | 2,584,269 | 1,934,197 | 2,185,410 | 836,710 | 991,822 | 1,831,333 | Upgrade
|
| Last Close Price | 51100.00 | 38650.00 | 44300.00 | 17800.00 | 21050.00 | 37500.00 | Upgrade
|
| PE Ratio | 1123.15 | - | 640.06 | 3588.03 | 121.16 | 97.10 | Upgrade
|
| Forward PE | 358.90 | 117.15 | 261.09 | 112.30 | 65.12 | 88.99 | Upgrade
|
| PS Ratio | 16.84 | 14.11 | 16.65 | 8.20 | 10.61 | 21.66 | Upgrade
|
| PB Ratio | 16.46 | 11.64 | 12.06 | 5.36 | 6.59 | 10.59 | Upgrade
|
| P/TBV Ratio | 27.00 | 11.96 | 12.18 | 5.43 | 6.68 | 10.74 | Upgrade
|
| P/FCF Ratio | 208.07 | 253.93 | 82.47 | 40.22 | - | - | Upgrade
|
| P/OCF Ratio | 187.11 | 209.40 | 75.76 | 35.71 | 1283.40 | 2065.25 | Upgrade
|
| PEG Ratio | - | 19.09 | 19.09 | 19.09 | 19.09 | 30.69 | Upgrade
|
| EV/Sales Ratio | 16.78 | 13.92 | 16.20 | 7.61 | 9.76 | 20.67 | Upgrade
|
| EV/EBITDA Ratio | - | 577.20 | 437.93 | 183.55 | 77.34 | 207.41 | Upgrade
|
| EV/EBIT Ratio | - | 8392.22 | 1253.51 | 555.66 | 98.21 | 308.56 | Upgrade
|
| EV/FCF Ratio | 207.22 | 250.60 | 80.26 | 37.30 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.18 | 0.43 | 0.26 | 0.29 | 0.10 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.11 | 0.19 | 0.05 | 0.06 | - | - | Upgrade
|
| Asset Turnover | 0.74 | 0.61 | 0.60 | 0.53 | 0.49 | 0.43 | Upgrade
|
| Inventory Turnover | 1.95 | 1.88 | 2.08 | 2.11 | 2.05 | 2.26 | Upgrade
|
| Quick Ratio | 0.82 | 1.29 | 2.10 | 2.97 | 4.35 | 4.61 | Upgrade
|
| Current Ratio | 2.01 | 2.46 | 3.02 | 3.92 | 5.37 | 5.61 | Upgrade
|
| Return on Equity (ROE) | 1.40% | -1.02% | 1.98% | 0.15% | 5.16% | 12.29% | Upgrade
|
| Return on Assets (ROA) | 1.16% | 0.06% | 0.48% | 0.46% | 3.02% | 1.80% | Upgrade
|
| Return on Capital (ROIC) | 1.45% | 0.08% | 0.61% | 0.56% | 3.64% | 2.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.30% | 0.10% | 0.90% | 0.80% | 5.70% | 3.00% | Upgrade
|
| Earnings Yield | 0.09% | -0.09% | 0.16% | 0.03% | 0.83% | 1.03% | Upgrade
|
| FCF Yield | 0.48% | 0.39% | 1.21% | 2.49% | -0.35% | -0.08% | Upgrade
|
| Buyback Yield / Dilution | 1.06% | -0.04% | 0.24% | 0.76% | -0.05% | -0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.